DnB Asset Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$850K Buy
12,898
+1,819
+16% +$116K ﹤0.01% 660
2025
Q4
$704K Buy
11,079
+869
+9% +$54.1K ﹤0.01% 661
2025
Q3
$561K Sell
10,210
-1,245
-11% -$51.3K ﹤0.01% 667
2025
Q2
$378K Buy
11,455
+1,021
+10% +$35.5K ﹤0.01% 662
2025
Q1
$419K Buy
10,434
+1,221
+13% +$56.1K ﹤0.01% 668
2024
Q4
$433K Buy
9,213
+1,826
+25% +$94.8K ﹤0.01% 670
2024
Q3
$390K Buy
7,387
+156
+2% +$8.7K ﹤0.01% 668
2024
Q2
$392K Buy
7,231
+645
+10% +$38.9K ﹤0.01% 663
2024
Q1
$462K Buy
+6,586
New +$509K ﹤0.01% 657

Other funds holding CYTK